Peer-reviewedCC BY-NC-ND 4.0Scientific Reports
Machine learning based regulatory T cells related gene signature for predicting the clinical outcome and immunotherapy benefits in skin cutaneous melanoma
Related
- A T-cell exhaustion-related signature for predicting response to immunotherapy among patients with lung adenocarcinoma
- A Hypoxia and EMT-Related Gene Signature for Predicting Prognosis and Immunotherapy Benefit in Hepatocellular Carcinoma.
- Development and internal validation of machine learning models for predicting lymph node metastasis in cutaneous head and neck melanoma
- A novel multimodal model integrating CT-based deep learning and clinical information for predicting 1-year OS of first-line immunotherapy in ES-SCLC patients
- Metabolic signature of phosphoethanolamine and arginine pathways predicts prognosis and immunotherapy resistance in lung adenocarcinoma
BibTeX
@article{zheng2026machine,
title = {{Machine learning based regulatory T cells related gene signature for predicting the clinical outcome and immunotherapy benefits in skin cutaneous melanoma}},
author = {Yuzhi Zheng and Xinnuo Chen and Zijian Wu and Changchun Cao and Jiangfeng Li},
journal = {Scientific Reports},
year = {2026},
month = oct,
doi = {10.1038/s41598-026-74478-4},
url = {https://www.nature.com/articles/s41598-026-74478-4},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Machine learning based regulatory T cells related gene signature for predicting the clinical outcome and immunotherapy benefits in skin cutaneous melanoma
AU - Yuzhi Zheng
AU - Xinnuo Chen
AU - Zijian Wu
AU - Changchun Cao
AU - Jiangfeng Li
PY - 2026
DA - 2026/10/06
JO - Scientific Reports
DO - 10.1038/s41598-026-74478-4
UR - https://www.nature.com/articles/s41598-026-74478-4
SN - 2045-2322
ER -